These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 35482355)

  • 1. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
    Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
    World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
    Zhao LY; Mei JX; Yu G; Lei L; Zhang WH; Liu K; Chen XL; Kołat D; Yang K; Hu JK
    Signal Transduct Target Ther; 2023 May; 8(1):201. PubMed ID: 37179402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the gut microbiome in gastrointestinal cancers.
    Mishra Y; Ranjan A; Mishra V; Chattaraj A; Aljabali AAA; El-Tanani M; Hromić-Jahjefendić A; Uversky VN; Tambuwala MM
    Cell Signal; 2024 Mar; 115():111013. PubMed ID: 38113978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.
    Jiang S; Ma W; Ma C; Zhang Z; Zhang W; Zhang J
    Gut Microbes; 2024; 16(1):2341717. PubMed ID: 38717360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiome and melanoma: A review.
    Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
    Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.
    Chrysostomou D; Roberts LA; Marchesi JR; Kinross JM
    Gastroenterology; 2023 Feb; 164(2):198-213. PubMed ID: 36309208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome in gastrointestinal cancer: a friend or foe?
    Liu Y; Baba Y; Ishimoto T; Gu X; Zhang J; Nomoto D; Okadome K; Baba H; Qiu P
    Int J Biol Sci; 2022; 18(10):4101-4117. PubMed ID: 35844804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
    Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
    Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.
    Shui L; Yang X; Li J; Yi C; Sun Q; Zhu H
    Front Immunol; 2019; 10():2989. PubMed ID: 32010123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
    Chen Y; Liu B; Wei Y; Kuang DM
    Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
    Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine.
    Wang L; Peng F; Peng C; Du JR
    Am J Chin Med; 2021; 49(3):609-626. PubMed ID: 33683187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy.
    Chattopadhyay I; Nandi D; Nag A
    Semin Cancer Biol; 2021 May; 70():98-111. PubMed ID: 32739479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
    Gately S
    Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies.
    Chen Y; Wang X; Ye Y; Ren Q
    Med Oncol; 2023 Dec; 41(1):25. PubMed ID: 38129370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.